2 completed, 1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Carcinoma of the Oropharynx: new trials by email Literature Review of Carcinoma of the Oropharynx trials Research Report on Carcinoma of the Oropharynx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs Stage III Breast Cancer, Stage IV Breast Cancer | Withdrawn | Travera Inc | 2024-11-01 | 2024-11-25 | ||
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) Pleural Effusion, Malignant, Ascites, Malignant | Completed | Travera Inc | 72 | 2022-07-15 | 2026-04-13 | |
| A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx HPPH - Dysplasia, Carcinoma of the Oral Cavity | Phase 1 | Completed | Roswell Park Cancer Institute | 29 | 2010-06-08 | 2018-10-16 |
Mouth Neoplasms (3) · Oropharyngeal Neoplasms (3) · Anus Neoplasms (2) · Appendiceal Neoplasms (2) · Breast Neoplasms (2) · Carcinoma (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Neuroendocrine (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Cholangiocarcinoma (2) · Esophageal Neoplasms (2) · Laryngeal Neoplasms (2) · Lung Neoplasms (2) · Mesothelioma (2)
Head and Neck Neoplasms (3) · Mouth Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Otorhinolaryngologic Diseases (3) · Otorhinolaryngologic Neoplasms (3) · Pharyngeal Diseases (3) · Pharyngeal Neoplasms (3) · Stomatognathic Diseases (3) · Adenocarcinoma (2) · Adenoma (2) · Adnexal Diseases (2) · Anus Diseases (2) · Breast Diseases (2) · Bronchial Neoplasms (2)
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (1)
Travera Inc (2) · Roswell Park Cancer Institute (1)
United States (2)
Hassan Arshad, MD (1) · Mark Stevens, Ph.D. (1) · Mark Stevens, Phd (1) · Rob Kimmerling, Phd (1) · Robert Kimmerling, Ph.D. (1)